Bell Potter says this ASX 300 share could rise 75%

Let's find out what the broker is recommending to clients today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you have a high tolerance for risk, then it could be worth looking closely at Alpha HPA Ltd (ASX: A4N).

That's because the team at Bell Potter believes this ASX 300 share could rise materially from current levels.

A young man punches the air in delight as he reacts to great news on his mobile phone.

Image source: Getty Images

What is Alpha HPA?

Alpha HPA is the owner of the HPA First Project in Gladstone, Queensland, which is aiming to supply high-purity aluminium-based products to the semiconductor, lithium-ion battery, and light emitting diode (LED) manufacturing sectors.

Bell Potter notes that the project's proprietary technology is expected to disrupt incumbent HPA production through delivering ultra-high purity products with significantly lower unit costs.

The broker highlights that a recent update revealed letters of intent and commercial supply agreements. It said:

A4N's positive marketing update points to product offtake Letters of Intent exceeding 12ktpa, further maturity in commercial supply agreements from Stage 1 production, adoption of HPA in semiconductor tooling, and product demand projections exceeding 50ktpa by 2030. Four new LOIs include: 324tpa for semiconductor thermal fillers (2 x LOIs to South Korea & Japan); 180tpa for catalyst applications; and up to 5,000tpa from a Tier-1 lithium-ion battery group which follows a multi-year cycle of product qualification.

Commercial supply agreements have been added with US and European semiconductor Chemical Mechanical Planarisation customers and with Japanese and South Korean semiconductor thermal filler customers. A4N's modelling sees demand for key products HPA and High Purity ATH exceeding 50ktpa by 2030, including around 30ktpa from the semiconductor sector.

Bell Potter thinks this leaves the ASX 300 share well-placed to unlock its debt funding. It adds:

The update puts A4N in a strong position to meet Conditions Precedent to draw on its $400m debt funding from Export Finance Australia and the Northern Australia Infrastructure Facility. A key CP was 100% offtake coverage from Stage 2 (10ktpa). We expect that A4N will now be working with the lenders on the basis that a significant offtake threshold has been reached, to enable debt release in 2H 2026.

In the interim, A4N is well funded, with $212m cash at the end of the last quarter. A4N's sales from its current smaller-scale Stage 1 facility are important market seeding to demonstrate the unmatched capability of A4N's HPA First products. The demand modelling, in particular from the AI data centre-driven semiconductor sector, adds further confidence with respect to the debt CPs and future expansion potential.

Big potential returns for this ASX 300 share

According to the note, Bell Potter has retained its speculative buy rating and $1.50 price target on Alpha HPA's shares.

Based on its current share price of 86 cents, this implies potential upside of approximately 75% for investors over the next 12 months.

Commenting on its speculative buy recommendation, Bell Potter concludes:

Over 2H 2026, we expect A4N to firm-up existing offtake LOI volumes and progress to sales contracts for Stage 2 capacity. A key catalyst will be drawing on the project's committed NAIF and EFA debt facility, which we expect in 2H 2026. A4N's recent commentary relating to potential volume expansions beyond Stage 2 give us further comfort on the long-term adoption of HPA by the semiconductor sector and therefore product demand. We have made no changes to our A4N valuation or positive outlook in this report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares which could improve by 25% to more than 100%

Looking for significant gains? Check these recommendations out.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A graphic showing three hands holding red paddles with the word BID, indicating a bidding war for an ASX share company
Broker Notes

Buy, hold, sell: L1 Long Short Fund, REA, Wesfarmers shares

Andrew Wielandt from DP Wealth Advisory reveals some stock tips for FY27.

Read more »

Young boy looks shocked as he lifts glasses above his eyes in front of a stock market graph. representing three ASX 300 shares hitting 52-week lows today
Broker Notes

Buy, hold, sell: Regis Resources, Mineral Resources, Woolworths shares

Can Woolworths shares outperform again in FY27? And what about these two mining stocks?

Read more »

An older couple hold hands as they bounce happily high in the air.
Broker Notes

2 struggling ASX shares tipped to rebound up to 15%

These stocks can recover in the next 12 months according to Morgans.

Read more »

A group of three men in hard hats and high visibility vests stand together at a mine site while one points and the others look on with piles of dirt and mining equipment in the background.
Broker Notes

How high does Macquarie think Fortescue shares will go?

The broker is positive on the company's outlook.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Broker Notes

Experts name 3 big-name ASX 200 shares to sell

These shares are in the bad books, but for what reason?

Read more »

Two smiling work colleagues discuss an investment at their office.
Broker Notes

Why Mesoblast shares could double in value

This biotechnology company just became less risky according to Bell Potter.

Read more »